SHL Telemedicine Ltd American Depositary Shares
SHLT
SHLT was delisted on the 2nd of April, 2025.
1 hedge funds and large institutions have $5.04M invested in SHL Telemedicine Ltd American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
28% less capital invested
Capital invested by funds: $6.96M → $5.04M (-$1.91M)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.89K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.55K |
SHLT Hedge Fund Activity: Q4 2023 in Review
1 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in SHL Telemedicine Ltd American Depositary Shares (SHLT) for Q4 2023, worth a combined $5.04M — down 28% from $6.96M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SHLT and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Sphera Funds Management, adding an estimated $1.89K. The largest seller was UBS Group, exiting entirely with an estimated $1.55K sold.
- 1 institutional investor held SHL Telemedicine Ltd American Depositary Shares (SHLT) as of Q4 2023, down from 2 in Q3 2023.
- Funds reported $5.04M of SHL Telemedicine Ltd American Depositary Shares stock for Q4 2023, down 28% quarter-over-quarter.
- 0 funds opened new SHL Telemedicine Ltd American Depositary Shares positions in Q4 2023 and 1 closed out, a net change of -1 holder.
- The largest SHL Telemedicine Ltd American Depositary Shares buyer in Q4 2023 was Sphera Funds Management, an estimated $1.89K added.
- The largest SHL Telemedicine Ltd American Depositary Shares seller in Q4 2023 was UBS Group, an estimated $1.55K sold.
Based on aggregated 13F filings for Q4 2023.